Varejao, who has been out with a leg injury, will reportedly miss the rest of the season after developing blood clot in his lower right lung, from NBA.com:
Cavaliers center Anderson Varejao recently developed a blood clot (small right lower lung pulmonary embolism) and was admitted to the Cleveland Clinic last Thursday (January 17th). He is being treated with blood thinners (anticoagulants) and is expected to stay at the Clinic for several days, while undergoing treatment and observation. He will need to remain on blood thinning medication for approximately three months. While Varejao is expected to fully recover, he will miss the remainder of the current Cavaliers season.
Quote from Cavaliers General Manager Chris Grant: “Clearly our players’ health is our top concern and we are disappointed for Anderson, and his family. We know what a competitor he is and how much he wants to be on the court helping his teammates. In the meantime, he has our full support and we look forward to welcoming him back as he recovers.”
The news is such a shame, given the career season Varejao was enjoying prior to the rise of all the health issues. The big man was leading the league in rebounds with 14.4, while scoring at a career-best 14.1 points. He was also a candidate to become traded to a contending team, but that notion is all but out the window with the sudden development of the blood clot.
Onto other news from around the league: